Jennifer Doudna and Feng Zhang have received separate grants from the National Human Genome Research Institute for CRISPR technology-based projects they both say have the potential to advance the tool's usefulness for human health purposes.
August 22, 2017
August 18, 2017
On Wednesday and Thursday (August 16-17, 2017) UC Berkeley welcomed about 300 people—scientists, CEOs, farmers, regulators, conservationists, and interested citizens—to its campus to take a hard look at the wünderenzyme known as Cas9.
August 16, 2017
Gloria Ortiz of the Evan Miller Research Group has is one of 39 new Gilliam fellows selected by The Howard Hughes Medical Institute.
August 14, 2017
Elemental sulfur, the most heavily used pesticide in California, may harm the respiratory health of children living near farms that use the pesticide, according to new research led by UC Berkeley.
August 10, 2017
August 9, 2017
The Green Science Policy Institute recently launched sixclasses.org, a website featuring a series of four-minute videos on the "Six Classes" of chemicals that are known to harm human health and the environment.
August 5, 2017
Newsweek spoke with Jennifer Doudna co-discover of the breakthrough gene-editing technique, about how quickly the technology is advancing and the progress she expects to see in the future.
August 3, 2017
UC Berkeley is hosting a two-day conference Aug. 16-17 that will bring together farmers, doctors, patients, environmentalists, consumers, nonprofits, community leaders and scientists to discuss potential applications of CRISPR technology, ranging from human and animal health to agriculture and conservation.
August 2, 2017
"It feels a bit like a 'one small step for (hu)mans, one giant leap for (hu)mankind' moment," Jennifer Doudna, a biochemist who helped discover the gene-editing method used, called CRISPR-Cas9, said in an email.
August 1, 2017
Chemistry professor Evan Williams and his co-investigators are the recipients of the NeuroNex Innovation Award for research on Chemical and Genetic Methods to Measure and Manipulate Neurons with Light.
July 31, 2017
Peidong Yang and fellow scientists discover unique thermoelectric properties in cesium tin iodide.
July 26, 2017
The University of California, along with the University of Vienna and Emmanuelle Charpentier, yesterday filed its opening brief with the U.S.
July 24, 2017
The paper, which will be published online July 20 in Science by Jennifer Doudna and her research group, used electron microscopy and X-ray crystallography, performed at the Advanced Light Source at Lawrence Berkeley National Laboratory, the Stanford Linear Accelerator Center, and the HHMI electron microscope facility at UC Berkeley, to capture structures of Cas1-Cas2 in the act of inserting vir
July 21, 2017
Jennifer Doudna faces an uncommon challenge for a scientist at the top of her form and the forefront of her field: While she watches her work produce "breathtaking" advances in the understanding of human biology, she's struggling with its ethi
July 20, 2017
Emanuel "Manny" Druga has been named the July 2017 recipient of the Chemistry Achievement Prize (CAP). Manny has been working at the College of Chemistry R&D shops as an electrician for the last 15 years. He has grown to love the close knit community and atmosphere at the College.
July 19, 2017
With one eye on potential bioterrorism threats, the Defense Advanced Research Projects Agency today announced $65 million in funding to seven projects around the country – including one led by UC Berkeley – to improve the safety and accuracy of gene editing.
July 17, 2017
The Department of Energy's Joint BioEnergy Institute (JBEI), led by Lawrence Berkeley National Laboratory (Berkeley Lab), was selected as one of four DOE Bioenergy Research Centers (BRCs) to receive funding in support of innovative research on biofuels and bioproducts.
John Hartwig, and post-doc Konstantin Troshin came up with a quick and easy way to trial and analyze those interactions using an Excel spreadsheet and equipment most chemists already have in their labs.
July 12, 2017
Research now shows that the countermeasure viruses came up with — inhibitory proteins referred to as anti-CRISPRs — can be used to improve CRISPR-Cas9 as a gene-therapy tool, decreasing off-target gene editing that could cause unwanted side effects.